Zocdoc, which had built its business as an online scheduling platform for doctors, quickly pivoted at the beginning of the pandemic to offer telehealth visits. The company recently raised $150 million from Francisco Partners.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
MedCity News
Amicus’s path to unseat Sanofi in rare disease gets steeper after Phase 3 miss
Amicus Therapeutics CEO John Crowley said the totality of data support the Pompe disease therapy’s submission to the FDA. That rolling application is on track for completion in the second quarter.
Shares1
Amicus Therapeutics aims to position its experimental Pompe disease treatment as the new standard of care, supplanting a therapy from Sanofi. But securing approval will require explaining to regulators why they should look past the treatment’s failure to achieve the main goal of a pivotal study.
The main goal of the Phase 3 study testing the Amicus drug, AT-GAA, was to measure how much further, on average, patients could walk in a six-minute test after 52 weeks of treatment. Pompe patients have an inherited enzyme deficiency that leads to a progressive weakening of their muscles.
Dr. Kathleen Jordan
Dr. Kathleen Jordan, SVP of Medical Affairs at Tia, is an Internal Medicine doctor and infectious disease specialist with more than two decades of clinical and leadership experience at the forefront of personalized care delivery. She also consults for both local and national organizations on issues regarding infection control, treatments, and the local and global response to COVID-19. Seen and cited as a healthcare expert on CNN, in the Washington Post, San Francisco Chronicle, Bustle, and a frequent guest on The Ronn Owens Report. Dr. Jordan most recently served as the Chief Medical Officer at Saint Francis Memorial, a Dignity Health hospital, working to improve the health of a complex community, starting new programs in infection control, substance use disorders, mental health, and LGTBQ care. Dr. Jordan is a graduate of Stanford University and UCLA School of Medicine, and in 2020 won the Bella Farrow Award for her innovation in healthcare while a physician